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In this work, we propose a new quick sol–gel procedure for bioglass nanoparticles production 
containing 10% mol of silver (AgBGs). These new AgBGs were characterized by Zeta 
potential analysis, scanning electron microscopy with X-ray microanalysis (SEM/EDS), X-ray 
powder diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and 
microbiological tests to confirm their bioactive and antibacterial properties. SEM showed 
that the average particle size was less than 200 nm and EDS confirmed the successful 
incorporation of Ag2O in the bioglass matrix. XRD confirmed the amorphous nature of the 
AgBGs and, after SBF immersion, revealed their bioactive behavior with the presence of 
crystalline phase of calcium silicate and phosphorus oxide, which were also detected by FTIR 
analysis. FTIR also confirmed the formation of typical siloxane bonds resulting from the 
condensation of silicate glass. Lastly, it is found that the developed AgBGs had an 
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antibacterial effect against two different types of bacteria, thus demonstrating their ability to 
reduce the bacterial infection within 16h. 
 
1. Introduction 
Due to their size and easy dispersability, nanoparticles can be applied in a multitude of 
already existing biomedical devices and strategies, enhancing mechanical properties and 
providing the bioactive character to a specific material, such as in the case of bioglass 
nanoparticles.[1,2] Nanoparticles may also work as independent nanodevices in applications, 
such as nanocarriers. In particular, when bioglasses were discovered, they radically changed 
the biomaterials field. For the first time, a chemical bond between implants and host tissue 
was possible, leaving behind a first generation of bioinert devices. This was the beginning of a 
second generation of bioactive materials capable of inducing a cellular response at their 
surface. Effectively, these materials were able to bond not only to bone, but to soft tissue as 
well, avoiding fibrous encapsulation. [1,3,4] 
It is also known that a common reason of failure in tissue integration by a biomaterial is the 
development of bacterial infection. In fact, the implantation of materials for prostheses and 
tissue regeneration is often associated with the administration of antibiotics. However, some 
disadvantages are connected with this prophylaxis, as allergic reactions, microbial flora 
depletion and bacterial resistance.[5] Ideally, the implant should have the ability to both 
regenerate bone tissue and to treat the infection by delivering an antibacterial agent in a 
controlled and continuous manner. For these reasons, many authors have recently proposed 
the modification of biomaterials with different antibacterial agents, but the silver has been 
suggested as one of the most promising antibacterial agent.[6-13] 
Silver has been known and used for centuries as one of the most interesting antibacterial 
material, due to its excellent broad-spectrum antimicrobial properties.[9,14] The bacteriostatic 
action of silver remains unclear, but it has been suggested that silver ions kill microorganisms 
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instantaneously by blocking their respiratory enzyme systems, while having no negative effect 
on human cells. [8,12,15] 
Regarding the production of silver doped bioactive nanoparticles in the system 
SiO2-CaO-P2O5-Ag2O through the sol-gel methodology, some interesting works have been 
already developed with different silver contents.[5,14,16-18] In particular, Bellantone et al.[16] 
developed a formulation with a 3 Wt(%) Ag2O, Delben et al.[17] studied different formulations 
with a maximum of 5 mol% Ag,  but  only El-Kady et al.[5] and Vulpoi et al.[18] synthesized 
nanoparticles with higher silver content (a maximum of 10 mol%). Attending that the addition 
of a medium silver content was not commonly considered, in the present work our interest 
was focused on the development of an alternative and simple sol-gel methodology for the 
synthesis of new silicate glass nanoparticles with 10 mol% of silver oxide, using the same 
bioglass precursors described in a previous protocol developed and optimized by our group 
for a ternary bioglass system.[19] Therefore, the main objective of the present study was to 
develop silver doped bioglass nanoparticles, which present the in vitro bioactivity already 
evidenced by our ternary system[19,20] and, simultaneously, demonstrate an antimicrobial 
behavior to avoid severe bone infections. The produced AgBGs were, then, characterized in 
order to confirm the successful addition of silver oxide onto the bioglass system, and also to 
attest their bioactive and antibacterial properties. Several characterization techniques were 
performed: Zeta potential analysis, scanning electron microscopy with X-ray microanalysis 
(SEM/EDS), X-ray powder diffraction (XRD), Fourier transform infrared spectroscopy 
(FTIR); and finally, their antibacterial effect was studied through the disk diffusion 
methodology, against two types of bacteria with distinct Gram stains related with the 
respective composition of their cell walls, namely Staphylococcus aureus (Gram-positive) and 
Escherichia coli (Gram-negative). 
 
2. Experimental Section 
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2.1. Materials 
Tetraethyl orthosilicate (TEOS) 99.90% was purchased by Merck Chemicals, nitric acid 
monohydrate 69% was obtained by VWR.  Ammonium phosphate dibasic, calcium nitrate 
tetra hydrate 99%, ethanol absolute, ammonia water (ammonium hydrogen phosphate 98%, 
maximum of 33% NH3), and hydrochloric acid (HCl) were acquired from Sigma. Silver 
Nitrate (AgNO3) was obtained by VWR. The ternary bioglass nanoparticles (BGs) used in this 
study were produced using the method developed and optimized in our research group.[19,20] 
For microbial tests, Mueller-Hinton agar (MHA) medium was purchased from 
ThermoScientific (Thebarton, SA, Australia) and standardized cultures of Staphylococcus 
aureus (ATCC 29213TM) and Escherichia coli (ATCC 25922TM) with 1.5x108 CFU were 
purchased from the American Type Culture Collection (Manassas, VA, USA). 
 
2.2. Methods 
2.2.1. Synthesis of silver doped bioglass nanoparticles (AgBGs) 
Silver doped bioglass nanoparticles were produced using a quick alkali-mediated sol-gel 
methodology optimized by our group for the production of BGs,[19] which was modified 
considering some procedures for synthesis of silver doped bioglass nanoparticles already 
reported in literature.[5,17,18] Then, this previous sol-gel methodology was adapted for the 
production of bioglass nanoparticles with medium silver content: [SiO2-CaO-P2O5-Ag2O 
(mol%):56-30-4-10] to maximize their antibacterial behavior and also to explore the effect of 
the Ag addition on their in vitro bioactivity. Firstly, to prepare the acidic solution (solution 
A), ethanol absolute was added to osmotized water, the pH value of this mixture was adjusted 
to 2 with nitric acid (2M) and, after 1 h, tetraethyl orthosilicate (TEOS, Si(OC2H5)4) was 
added. This solution A was maintained under stirring during 1 h for the acidic hydrolysis of 
the precursor of SiO2 [Si(OC2H5)4]. Then, for producing the solution B, calcium nitrate 
tetrahydrate, ammonium phosphate dibasic and silver nitrate were sequentially added to 
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osmotized water and the pH value was adjusted to 11.5 with ammonium hydroxide solution. 
This reaction mixture was kept under stirring for 1h to the basic hydrolysis of those precursors 
of CaO [Ca(NO3)2.4H2O)], P2O5 [(NH4)2HPO4] and Ag2O [AgNO3]. 
Under smooth stirring, the solution A was slowly added to the solution B drop-by-drop and, 
during this step, the pH value of solution B was maintained at 11.5 using ammonia hydroxide 
solution. Then, the final solution was kept under stirring for 48 h in order to complete the 
condensation reaction that leads to gelation of bioglass. After this period, the stirring was 
stopped for precipitation of the gel particles, the supernatant was carefully removed and the 
precipitated gel was washed with osmotized water, at least three times. Finally, based on the 
thermal treatment described by Delben et al.,[17] after drying the obtained gel at 130°C for 24 
h in an oven to evaporate the alcohol and water, and the obtained xerogel was treated at 
600°C for 4 h to eliminate organic solvents, obtaining the AgBG powder. 
2.2.2. Characterization of AgBGs 
The Zeta potential, ζ, was determined with 0.06% (w/v) AgBGs suspensions prepared with 
0.15M NaCl solution under magnetic stirring for 30 min, and further ultrasonic dispersion at 
25ºC during 15 min. The Zeta potential of the nanoparticles was measured three times by a 
Zetasizer equipment (Nano-ZS) from Malvern Instruments with a Dispersion Technology 
Software (DTS). 
The morphology and composition of the glass powders were analyzed using SEM and the 
elemental composition of the bioglass powders was determined by EDS. X-ray diffraction 
(XRD) experiments were performed on a Bruker AXS D8 Discover with Cu-Kα radiation 
(λ=1.54060Å), scanning from 15° to 60° at a speed of 0.04°s-1. The analysis for phase 
identification was performed using analytical software EVA. The crystalline phases were 
indexed using the ICDD database (International Center for Diffraction Data). Fourier-
transform infrared (FTIR) spectroscopy analysis was carried out in a PERKIN-ELMER 1600 
FTIR spectrometer in Attenuated Total Reflection, ATR, mode as this technique is simpler to 
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use than the conventional transmission mode. The sample preparation only required the 
scratching of glasses powders into the SiC abrasive sticks. The FTIR spectra were recorded 
from 400 to 4000 cm-1. 
2.2.3. In vitro bioactivity study 
Standard in vitro bioactivity studies were conducted immersing the synthesized AgBGs in a 
simulated body fluid, SBF, solution since it simulates the concentration of ionic species 
presents in human blood plasma. The SBF solution was prepared by following the Kokubo 
and Takadama protocol[21] and its pH was adjusted to 7.4. Each glass coverslips with 10x10 
mm2 was coated with carbon tape containing AgBGs and, then, they were immersed during 7 
and 14 days in 25 mL of SBF solution at 37ºC. After removing from SBF solution, these glass 
pieces were cleaned with ultrapure water and dried at room temperature. The formation of 
apatite was characterized by Transform Infrared spectroscopy (FTIR) and X-ray diffraction 
(XRD) analysis. 
2.2.4. Microbiological analysis 
The antimicrobial properties of AgBGs nanoparticles were tested, in comparison with the 
ternary formulation (BGs), through the disk diffusion methodology. Briefly, circular glass 
coverslips were coated with few drops of 5 mg.mL-1 AgBGs and BGs water suspensions, and 
then, they were placed on top of a Mueller-Hinton agar plate inoculated with 1.5x108 CFU of 
a standardized culture of Staphylococcus aureus (+) and Escherichia coli (-), both with 
OD600 of approximately 0.1, and incubated for 16h at 37ºC. The formation of an inhibition 
zone surrounding the coated glass coverslips was used as indicator of antibacterial activity. 
3. Results and discussion 
Since the sol-gel methodology has been commonly used to synthesize silicate glass, we 
proposed a new procedure for AgBGs production through the modification of the sol-gel 
methodology developed by our group for ternary BGs synthesis.[19,20] This previous sol-gel 
procedure involves a two-step acid-base catalysis, where the mixture of an acidic solution 
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(water+ethanol+Si(OC2H5)4) catalyzed by citric acid with a basic solution 
(water+(NH4)2HPO4+Ca(NO3)2.4H2O) catalyzed by ammonia water, leads to the 
condensation (gelation) of the precursors. Alcohol and water were the byproducts of this 
condensation reaction, which evaporated during drying step forming a xerogel.[3,19] Based on 
the procedure of El-Kady et al.,[5] we only replaced citric acid by nitric acid as the catalyst of 
the acidic solution (solution A) and, comparing with the previous procedure for the ternary 
formulation,[19] it increased the rate of condensations reactions and reduced the gelation time.  
Firstly, the zeta potential of the silver doped bioglass nanoparticles was investigated in a 
physiological saline medium (0.15M NaCl solution) and the produced AgBGs presented a 
potential value of -22.90.1 mV at pH 5.5 and, in comparison with the zeta potential 
determined for ternary bioactive nanoparticles (-15.70.5 mV), this result indicated that silver 
doped nanoparticles have stability and they could better resist to aggregation.[22] It is mostly 
known that a negative zeta potential is crucial to promote the bioactive behavior,[23] since 
negative surfaces enhance the stable formation of surface apatite. So, it can be concluded that 
the developed silver doped nanoparticles presented an adequate zeta potential for the 
envisaged application. 
 
Fig. 1. Representative SEM images of the AgBGs (a) before and (b) after thermal treatment. 
 
Fig. 1(a) shows the SEM image of the gel phase (xerogel) of AgBGs, while Fig. 1(b) shows 
the SEM image of AgBGs after calcination at 600ºC. SEM images revealed that the grain size 
of samples was less than 200 nm. It can be seen that the morphology of the nanoparticles is 
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more spherical and presents less agglomeration on the xerogel, which probably indicates that 
thermal treatment promotes the agglomeration of AgBGs, changing their morphology and 
reducing their final grain size.  
Through the EDS, it was possible to quantify the final ratios of silver doped bioactive 
nanoparticles in terms of weight percentage, Wt(%), after and before the calcination step. The 
EDS results are shown in Table 1 and the quantitative analysis presents deviations regarding 
the initial formulations: only Si is at the original percentage and P is five times higher, and 
consequently, Ca is 15% below the original percentage. 
Table 1. Quantitative EDS analysis for the main precursors of AgBGs sol-gel and AgBGs 
after thermal treatment. 
Element AgBGs Sol-gel 
Wt(%) 
AgBGs (130ºC+600ºC) 
Wt(%) 
Si 21.7 16.3 
Ca 9.7 12.5 
Ag 2.1 1.9 
P 1.6 1.5 
 
The reasons for these differences may be the removal of free calcium ions during the washing 
step. Indeed, in the sol stage, almost 100% of Ca dissolves in the pore liquor as calcium 
nitrate, and it will only deposit in the drying step. Therefore, the final composition of AgBGs 
can be changed if the pore liquor is washed before drying, removing the calcium that was not 
incorporated in the silica or phosphoric gel network. This fact could be related with the 
variation in values obtained, as the experimental procedure followed in this work included a 
washing step, which is crucial to remove the ammonia from the precipitate. Nevertheless, the 
EDS analysis confirmed that the produced nanoparticles contained silver. It can be seen that 
the analyzed samples presented silica, calcium and phosphorous compositions that were 
typically detected for any silicate bioglass [12,22] and, also as expected, the silver content. 
Therefore, the sol-gel procedure proposed in the present work allowed a successful 
incorporation of silver ions in the composition of the bioglass nanoparticles. 
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Fig. 2 shows the XRD pattern of AgBGs before (0 days) and after SBF immersion (7 and 14 
days).  
 
Fig. 2. XRD diffractograms of AgBGs obtained before and after the immersion in SBF for 7 
and 14 days. Typical crystalline peaks of apatite-like phase were indicated. 
 
Before SBF immersion, as expected, XRD diffractrogram presents an amorphous profile, only 
presenting the crystalline phases of calcium silicate and phosphorus oxide. 
In fact, it is well known that glass is an amorphous inorganic material with no detectable 
diffraction maxima, but it seems that the thermal treatment process leads to the typical 
crystalline peaks of apatite-like phase (tricalcium phosphate).[19] On the other hand, the 
precipitation of tricalcium phosphate can occur from the amorphous structure of silica-based 
bioglasses during the sol-gel process in the aqueous environment.[16] After SBF immersion, 
some bands tend to disappear due to the decrease of Si percentage after SBF immersion, but 
all spectra revealed some typical crystalline peaks of apatite-like phase indicated at 2ɵ=15 to 
35o, as previously reported in other works.[7,17-19,24] Attending these results, it was possible to 
conclude that these AgBGs presented in vitro bioactive character. Moreover, in accordance 
with El-Kady et al.[5] and Vulpoi et al.,[18] our results suggest that the incorporation of a 
medium amount of silver into the bioglass system does not affect its bioactivity behavior. 
The FTIR spectra of AgBGs, after and before SBF immersion, were shown in Fig. 3.  
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Fig. 3. FTIR spectra of AgBGs obtained before and after the immersion in SBF for 7 and 14 
days. 
 
After SBF immersion, it can be seen the band corresponding to Si–O–Si (1000–1200 cm-1) 
asymmetric stretching vibration, the one attributed to the Si-O-S (725–800 cm-1) symmetric 
stretching vibration, and another one corresponding to the Si-O-Si (450–480 cm-1) bending 
mode, similarly with some characterization already reported.[5,16,18]  
The bands represented in Fig. 3 are the typical ones in literature concerning bioglass 
nanoparticles,[5,19] which revealed the formation of crystalline apatite-like phase confirming 
the bioactive character of the produced AgBGs. In fact, Luz et al.[19] reported similar bands 
with ternary BGs and El-Kady et al.[5] also showed that AgBGs presents the similar bands of 
those ternary system nanoparticles. 
Finally, the antimicrobial properties of the synthesized nanoparticles were also investigated. 
Fig. 4 shows representative images of the results obtained from the antibacterial tests 
performed with AgBGs and BGs (as control). Based on the region of inhibition observed in 
these images, even after 16h, the AgBGs clearly evidenced an antibacterial effect against 
S.aureus and E.coli, in accordance with the findings reported in some previous works, where 
silver nanoparticles with similar formulations were also characterized.[5,9,16] 
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Fig. 4. Images of glass coverslips coated with BGs and AgBGs, 16h after being placed on top 
of a Mueller-Hinton agar plate with S.aureus(+) and E.coli(-)  (1.5x108 CFU) incubated at 
37ºC. Scale bar represents 8000 μm. 
 
Since ternary nanoparticles did not present microbial growth inhibition, it can be concluded 
that the addition of silver on the AgBGs provided their antimicrobial behavior. In the present 
study, it was tested bioglass nanoparticles doped with a medium silver content (10% mol), in 
accordance with Chatzistavrou et al.[13] that already reported the bactericidal action of silver 
nanoparticles, even for formulations with a lower concentration of Ag. Bellantone et al.[9] also 
investigated the effect of AgBGs with different Ag2O contents on S. aureus and E. coli and 
they suggested that the antibacterial action of silver nanoparticles can be attributed to the 
leaching out of silver ions from the glass structure. Moreover, this antibacterial effect was 
also reported by Feng et al. and Kim et al.,[8] which suggested that silver ions dissolved out in 
the medium could react with bacterial metabolism, inhibiting its growth. 
4. Conclusions 
New silver doped bioglass nanoparticles [SiO2-CaO-P2O5-Ag2O (mol%):56-30-4-10] were 
successfully prepared, following an alkali-mediated sol-gel methodology. Their Zeta potential 
values proved their stability and also their bioactive behavior. SEM analysis evidenced the 
production of nanosized particles and EDS quantitative analysis confirmed the successful 
incorporation of the silver on these bioglass nanoparticles. XRD patterns showed the 
crystalline peaks of apatite-like phase and FTIR spectra showed characteristic peaks of the 
siloxane bonds formed during the condensation reaction of silicate glasses. The 
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microbiological tests revealed that the produced AgBGs had an antibacterial effect against 
two different types of bacteria, which suggest their potential ability to inhibit bone infections. 
Summarizing, the proposed sol-gel procedure provide a quick and effective production of 
nanosized and antibacterial AgBGs with medium content of silver, without compromising 
their in vitro bioactivity behavior. The synthesized silver doped nanoparticles revealed 
promising properties that could be implemented in several orthopedic applications, since the 
combination of bioactive with antibacterial properties is crucial to reduce the risk of post-
surgery complications, mostly caused by severe bacterial infections upon implantation. 
 
Received: ((will be filled in by the editorial staff)) 
Revised: ((will be filled in by the editorial staff)) 
Published online: ((will be filled in by the editorial staff)) 
 
 
[1] N. M. Alves, I. B. Leonor, H. S. Azevedo, R. L. Reis, J. F. Mano, J. Mater. Chem. 2010, 
20, 2911. 
[2] M. De, P. S. Ghosh, V. M. Rotello, Adv. Mater. 2008, 20, 4225. 
[3] L. L. Hench, Curr. Opin. Solid State Mater. Sci. 1997, 2, 604. 
[4] L. L. Hench, J. Mater. Sci. Mater. Med. 2006, 17, 967. 
[5] A. M. El-Kady, A. F. Ali, R. A. Rizk, M. M. Ahmed, Ceram. Int. 2012, 38, 177. 
[6] S. Silver, L. T. Phung, Ann. Rev. Microbiol. 1996, 50, 753. 
[7] M. Shirkhanzadeh, M. Azadegan, J. Mater. Sci. Mater. Med. 1998, 9, 385. 
[8] T. N. Kim, Q. L. Feng, J. O. Kim, J. Wu, H. Wang, G. C. Chen, F. Z. Cui, J. Mater. Sci. 
Mater. Med. 1998, 9, 129. 
[9] M. Bellantone, N. J. Coleman, L. L. Hench, J. Biomed. Mater. Res. 2000, 51, 484.  
[10] J. H. Crabtree, R. J. Burchette, R A. Siddiqi, I. T. Huen, L. L. Hadnott, A. Fishman, Perit. 
Dial. Int.: J. Int. Soc. Perit. Dial. 2003, 23, 368. 
[11] S. A. Jones, P. G. Bowler, M. Walker, D. Parsons, Wound Repair Regen. 2004, 12, 288. 
[12] B. S. Liu, T. B. Huang, Macromol. Biosci. 2008, 8, 932.  
[13] X. Chatzistavrou, J. C. Fenno, D. Faulk, S. Badylak, T. Kasuga, A. R. Boccaccini, P. 
Papagerakis, Acta Biomater. 2014, 10, 3723. 
[14] E. Vernè, S. D. Nunzio, M. Bosetti, P. Appendino, C. Vitale Brovarone, G. Maina, M. 
Cannas, Biomaterials 2005, 26, 5111. 
[15] Q. L. Feng, J. Wu, G. Q. Chen, F. Z. Cui, T. N. Kim, J. O. Kim, J. Biomed. Mater. Res. 
2000, 52, 662. 
[16] M. Bellantone, N. J. Coleman, L. L. Hench, Key Eng. Mater. 2001, 192, 597. 
[17] J. R. J. Delben, O. M. Pimentel, M. B. Coelho, P. D. Candelorio, L. N. Furini, F. Alencar 
dos Santos, F. S. de Vicente, A. A. S. T. Delben, J. Therm. Anal. Calorim. 2009, 97, 433.  
[18] A. Vulpoi, L. Baia, S. Simon, V. Simon, Mater. Sci. Eng. 2012, 32, 178. 
[19] G. M. Luz, J. F. Mano, Nanotechnology 2011, 22, 494014. 
[20] G. M. Luz, J. F. Mano, J. Nanopart. Res. 2013, 15, 1. 
[21] T. Kokubo, H. Takadama, Biomaterials 2006, 27, 2907. 
    
 13 
[22] A. Doostmohammadi, A. Monshi, R. Salehi, M. H. Fathi, Z. Golniya, A. U. Daniels, 
Ceram. Int. 2011, 37, 2311. 
[23] H. H. Lu, S. R. Pollack, P. Ducheyne, J. Biomed. Mater. Res. 2000, 51, 80. 
[24] D. S. Couto, N. M. Alves, J. F. Mano, J. Nanosci. Nanotech. 2009, 9, 1741. 
 
